Michael Schneider

456 total citations
21 papers, 271 citations indexed

About

Michael Schneider is a scholar working on Psychiatry and Mental health, Toxicology and Pharmacology. According to data from OpenAlex, Michael Schneider has authored 21 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 4 papers in Toxicology and 3 papers in Pharmacology. Recurrent topics in Michael Schneider's work include Schizophrenia research and treatment (8 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers) and Electroconvulsive Therapy Studies (3 papers). Michael Schneider is often cited by papers focused on Schizophrenia research and treatment (8 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers) and Electroconvulsive Therapy Studies (3 papers). Michael Schneider collaborates with scholars based in Germany, Austria and Brazil. Michael Schneider's co-authors include Cheryl L. Stucky, Martin Koltzenburg, Kathryn M. Albers, Brian M. Davis, Sermin Toto, R. Grohmann, Timo Greiner, Martin Heinze, Olga Geisel and Stefan Bleich and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Michael Schneider

20 papers receiving 262 citations

Peers

Countries citing papers authored by Michael Schneider

Since Specialization

Citations

This map shows the geographic impact of Michael Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schneider more than expected).

Fields of papers citing papers by Michael Schneider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schneider. The network helps show where Michael Schneider may publish in the future.

Co-authorship network of co-authors of Michael Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Schneider. A scholar is included among the top collaborators of Michael Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Schneider. Michael Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Age and Sex Differences in Adverse Events Associated With Antipsychotics: An Analysis of the FDA Adverse Events Database 2025 ·International Journal of Geriatric Psychiatry ·(unknown), Jens‐Uwe Peter, Michael Schneider, (unknown), Oliver Zolk	1
2	Pharmacotherapy of psychiatric inpatients with mental and behavioral disorders caused by sedatives or hypnotics (F13): Results from an observational pharmacovigilance program between 2000 and 2017 2025 ·Addiction Science & Clinical Practice ·(unknown), (unknown), Sermin Toto, Johanna Seifert, R. Grohmann, Martin Heinze, Oliver Zolk, (unknown), Michael Schneider, Timo Greiner	0
3	Sexual dysfunctions associated with antipsychotic drug intake: a retrospective analysis of the FDA adverse events reporting system (FAERS) 2025 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·J. Engel, (unknown), (unknown), Oliver Zolk, Timo Greiner, Martin Heinze, Pichit Buspavanich, Michael Schneider	2
4	Age and sex differences in outpatient antipsychotic prescriptions for schizophrenia: a claims data study 2024 ·European Archives of Psychiatry and Clinical Neuroscience ·(unknown), Jens‐Uwe Peter, Michael Schneider, Martin Heinze, Oliver Riedel, (unknown), Ulrike Haug, Oliver Zolk	3
5	Edema related to treatment with psychotropic drugs 2024 ·Journal of Neural Transmission ·J. Engel, (unknown), Oliver Zolk, Timo Greiner, Martin Heinze, Sermin Toto, Johanna Seifert, Stefan Bleich, (unknown), R. Grohmann, Michael Schneider, Susanne Stübner	5
6	A case series of serious and unexpected adverse drug reactions under treatment with cariprazine 2021 ·SHILAP Revista de lepidopterología ·(unknown), Johanna Seifert, Dirk O. Stichtenoth, Christoph Schroeder, Adrian Groh, Gregor R. Szycik, Detlef Degner, (unknown), Michael Schneider, (unknown), Eckart Rüther, Stefan Bleich, R. Grohmann, Sermin Toto	4
7	Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study 2021 ·The World Journal of Biological Psychiatry ·Oliver Zolk, Timo Greiner, Michael Schneider, Martin Heinze, (unknown), (unknown), R. Grohmann, Stefan Bleich, (unknown), Sermin Toto, Johanna Seifert	6
8	Psychotropic drug-induced hyponatremia: results from a drug surveillance program–an update 2021 ·Journal of Neural Transmission ·Johanna Seifert, Martin Letmaier, Timo Greiner, Michael Schneider, (unknown), (unknown), Stefan Bleich, R. Grohmann, Sermin Toto	19
9	Severe weight gain as an adverse drug reaction of psychotropics: Data from the AMSP project between 2001 and 2016 2020 ·European Neuropsychopharmacology ·Michael Schneider, (unknown), Sermin Toto, Stefan Bleich, R. Grohmann, Martin Heinze, Timo Greiner	21
10	Pharmacotherapy of psychiatric inpatients with adjustment disorder: current status and changes between 2000 and 2016 2019 ·European Archives of Psychiatry and Clinical Neuroscience ·Timo Greiner, (unknown), Sermin Toto, Stefan Bleich, R. Grohmann, Frank Faltraco, Martin Heinze, Michael Schneider	7
11	Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993–2015 2018 ·European Archives of Psychiatry and Clinical Neuroscience ·Michael Schneider, (unknown), Timo Greiner, (unknown), Stefan Bleich, Sermin Toto, R. Grohmann, Susanne Stübner, Martin Heinze	11
12	Priapism induced by various psychotropics: A case series 2018 ·The World Journal of Biological Psychiatry ·Timo Greiner, Michael Schneider, (unknown), Sermin Toto, Stefan Bleich, R. Grohmann, Martin Heinze	9
13	Effects of repetitive imagination of alcohol consumption on craving in alcohol-dependent patients: A pilot study 2016 ·Addictive Behaviors Reports ·Olga Geisel, Julia Behnke, Michael Schneider, Klaus‐Dieter Wernecke, Christian Müller	6
14	Characteristics of Social Network Gamers: Results of an Online Survey 2015 ·Frontiers in Psychiatry ·Olga Geisel, (unknown), (unknown), Michael Schneider, Christian Müller	14
15	Serum levels of brain-derived neurotrophic factor in patients with internet use disorder 2013 ·Psychiatry Research ·Olga Geisel, (unknown), Michael Schneider, Rainer Hellweg, Christian Müller	16
16	Correction: N-octanoyl-Dopamine Is an Agonist at the Capsaicin Receptor TRPV1 and Mitigates Is Chemia-Induced Acute Kidney Injury in Rat 2012 ·PLoS ONE ·Charalambos Tsagogiorgas, Johannes Wedel, (unknown), Michael Schneider, (unknown), Wolfgang Greffrath, Rolf‐Detlef Treede, (unknown), (unknown), (unknown), B.K. Krämer, Manfred Thiel, Peter Schnuelle, Benito Yard, Simone Hoeger	4
17	N-octanoyl-Dopamine Is an Agonist at the Capsaicin Receptor TRPV1 and Mitigates Is Chemia-Induced Acute Kidney Injury in Rat 2012 ·PLoS ONE ·Charalambos Tsagogiorgas, Johannes Wedel, (unknown), Michael Schneider, (unknown), Wolfgang Greffrath, Rolf‐Detlef Treede, (unknown), (unknown), Rüdiger Waldherr, Bernhard K. Krämer, Manfred Thiel, Peter Schnuelle, Benito Yard, Simone Hoeger	37
18	Profibrotic cytokines and lymphocyte proliferation in stable renal allograft recipients treated with or without cyclosporine A 2006 ·Clinical Immunology ·Johannes Waiser, Michael Schneider, (unknown), Torsten Slowinski, Petra Glander, Gunilla Einecke, Klemens Budde, Hans‐Hellmut Neumayer, Torsten Böhler	4
19	Pharmacodynamic monitoring of lymphocyte proliferation and TGF-β1 expression at cyclosporine a (CyA) trough levels (C0) and 2 hours after intake (C2) of CyA in human renal allograft recipients 2001 ·Transplantation Proceedings ·Torsten Böhler, Klemens Budde, Michael Schneider, (unknown), (unknown), Gunilla Einecke, Fritz Diekmann, Lutz Fritsche, (unknown), H.‐H. Neumayer, Johannes Waiser	8
20	Overexpression of Nerve Growth Factor in Skin Selectively Affects the Survival and Functional Properties of Nociceptors 1999 ·Journal of Neuroscience ·Cheryl L. Stucky, Martin Koltzenburg, Michael Schneider, (unknown), Kathryn M. Albers, Brian M. Davis	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact